USPTO serial 79213964
TICKPLEX
Reviewed by CopyMark Law Group
Reg. 5634880Status 707Registered
- Filing date
- Status date
- Registration date
- Dec 25, 2018
- Examiner
- ROACH, APRIL K
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with TICKPLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth A. Cominolli
Elizabeth A. Cominolli Markert & Cominolli PLLC75 S. Clinton Ave., Suite 510Rochester, NY 14604United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; [ chemical substances, chemical materials and chemical preparations, and chemical elements for use in manufacture, namely, chemical additives for use in manufacture of pharmaceuticals; ] chemicals for use in analysis, namely, chemical preparations for laboratory analysis, other than medical and veterinary analysis; diagnostic preparations used in science; diagnostic preparations, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; chemical compositions and materials in the nature of solutions for use in science; chemical reagents, other than for medical or veterinary purposes; Diagnostic reagents for medical laboratory use; Chemical and diagnostic reagents for use in antibody screening and pathogen identification; Chemical and diagnostic reagents for use in conducting enzyme-linked immunosorbent assays; chemical test reagents, other than medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent mixtures, other than for medical or veterinary use; [ proteins for use in science, namely, protein arrays for scientific research; ] reagents for scientific purposes, namely, reagents for scientific research; reagents for research purposes; reagents for medical research; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents, other than for medical use for sale in kit form namely, for scientific research; reagents in kit form for conducting enzyme-linked immunosorbent assay, other than medical and veterinary use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; monoclonal antibody reagents, other than for medical use; [ chemical components for producing a radiolabeled monoclonal antibody for industrial or scientific use; ] Bacteria and bacteriological preparation for use in conducting enzyme-linked immunosorbent assays, and for use in antibody screening and pathogen identifications, and not for medical and veterinary use; [ bacteriological preparations other than for medical and veterinary use, namely, bacteria for use in pharmaceutical manufacturing; ] protein raw material, namely, for [ use in the manufacturing of pharmaceuticals, food supplements and for ] laboratory use in scientific research [ ; carbon; silver nitrate; oxide for industrial use ] | ACTIVE | — |
| 005 | Sanitary preparations for medical purposes; chemical preparations for medical purposes, namely, [ for treating hypertension, ] reagents for medical diagnosis; bacterial preparations for medical [ and veterinary ] use; bacteriological preparations for medical [ and veterinary ] use; antigens, namely, diagnostic reagents for medical use; diagnostic preparations, namely, diagnostic reagents for medical use; diagnostic reagents for medical use; diagnostic reagents for medical use for sale in kit form; chemical reagents for medical [ or veterinary ] purposes; clinical diagnostic reagents; clinical medical reagents; medical diagnostic reagents and assays for detecting pathogens am co-infections in kit form; antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; reagent paper for medical [ or veterinary ] purposes | ACTIVE | — |
| 009 | [ Scientific apparatus and instruments, namely, laboratory glassware, laboratory flasks, laboratory swabs, laboratory, magnetic separators, spectrometers; laboratory instruments, other than for medical use, namely, chromatography apparatus and columns, centrifuges as well as for the detection of pathogens and toxins in a biological sample for research use; ] laboratory instruments for the detection of pathogens and toxins in a biological sample for research use; laboratory trays; incubation plates for scientific or laboratory use | ACTIVE | — |
| 010 | Medical apparatus and instruments in the field of pathogen and toxin detection and identification; testing apparatus for medical purposes, namely, blood testing apparatus [ ; medical instruments for infectious disease testing, namely, biosensors for detecting infectious disease; diagnostic testing instruments for use in detection infectious diseases, namely, biosensors for detecting infectious disease ] | ACTIVE | — |
| 042 | [ Scientific and technological services and research and design relating thereto, namely, scientific research and development in the field of pharmaceutical and biotechnology; industrial analysis and research services in the field of pharmaceuticals; research and development of new products for others; research and development services in the field of antibody technology; research and development services in the field of antibodies; research and development services in the field of bacteriology; scientific laboratory services; laboratory research in the field of bacteriology, pharmaceuticals, antibodies, pathogens and toxins; ; laboratory testing in the field of new pharmaceutical products; Laboratory testing of antibodies, pathogens and toxins, laboratory testing of patient samples for the detection and identification of antibodies, pathogens and toxins; Consultancy in the field of laboratory testing, namely medical laboratory services consultancy relating to laboratory testing and new pharmaceutical products; biochemical research and development; biochemical research and analysis; chemical analysis; bacteriological research; laboratory services, namely scientific research in the field of production of monoclonal antibodies ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Te?ted Oy
- Other trademarks owned by Jyväskylän yliopisto
- Other trademarks owned by Te?ted Oy
- Other trademarks owned by Te?ted Oy
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named TICKPLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 29, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 28, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jun 11, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 29, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 26, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 20, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 29, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 29, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Apr 29, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 28, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 19, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 6, 2024 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Mar 21, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 25, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 31, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 21, 2019 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 20, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 7, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Apr 5, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 5, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 25, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 25, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 9, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 9, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 19, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 19, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 20, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 20, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 20, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 23, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 23, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 20, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 20, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 13, 2017 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 22, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 22, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 17, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |